Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease
<p>Abstract</p> <p>Background</p> <p>Transcriptional dysregulation is an early, key pathogenic mechanism in Huntington's disease (HD). Therefore, gene expression analyses have biomarker potential for measuring therapeutic efficacy in pre-clinical trials, particular...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-10-01
|
Series: | Molecular Neurodegeneration |
Online Access: | http://www.molecularneurodegeneration.com/content/3/1/17 |